Search for: "Daniel v. Ouellette" Results 1 - 15 of 15
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Apr 2019, 2:33 pm by Lisa Larrimore Ouellette
Ouellette (@PatentScholar) April 5, 2019David Olson (@PIEBCLaw): How can patentees use licenses to price discriminate under current exhaustion law post-Impression v. [read post]
30 Sep 2015, 7:11 am by Jason Rantanen
Guest post by Daniel Hemel, Assistant Professor at the University of Chicago Law School, and Lisa Larrimore Ouellette, Assistant Professor at Stanford Law School. [read post]
11 Apr 2019, 5:32 am by Eric Goldman
NLRB * Scribd Must Comply With The Americans With Disabilities Act * Another Ruling that the Americans with Disabilities Act Doesn’t Apply to Websites–Ouellette v. [read post]
18 Dec 2012, 12:33 pm by Luke Rioux
Ouellette 2012 ME 11Self defense applies to reckless conduct. [read post]
24 Jun 2016, 9:05 am by Amy Howe
At Legal Aggregate, Lisa Ouellette analyzes the Court’s recent decision in Cuozzo Speed Technologies v. [read post]
27 Mar 2015, 10:00 am by Guest Blogger
Daniel Hemel and Lisa Ouellette have already situated IP regimes among a variety of other government policy levers designed to affirmatively encourage innovation and market entry, including prizes, grants, and tax incentives [read post]
20 Jun 2016, 3:12 am by Amy Howe
” In another post at Legal Aggregate, Lisa Ouellette weighs in on the Court’s recent ruling in Halo Electronics v. [read post]
21 Jan 2015, 2:46 am by Amy Howe
  Commentary comes from Lisa Larrimore Ouellette at Written Description. [read post]
31 May 2017, 4:59 am by Edith Roberts
In Esquivel-Quintana v. [read post]
6 Jun 2017, 7:37 am by Dennis Crouch
  (Professors Lisa Ouellette and Daniel Hemel addressed it in a blog entry cross-posted at Written Description and Whatever Source Derived. [read post]
6 Oct 2014, 5:36 am by Amy Howe
  At Written Description, Lisa Larrimore Ouellette previews next week’s argument in Teva Pharmaceuticals v. [read post]
24 Apr 2020, 6:58 am by Lisa Larrimore Ouellette
As Daniel Hemel and Lisa Ouellette have written, “[g]overnments can offer strong incentives to drug makers while ensuring affordability by committing to patent buyouts for effective treatments. [read post]
12 Apr 2013, 9:14 am by Rebecca Tushnet
  Compare Daniel Gervais et al. [read post]
27 Apr 2017, 1:30 am by Thaddeus Mason Pope, JD, PhD
John's University School of LawKatherine Schostok, DePaul University College of LawAllison Winnike, University of Houston Law Center 5:00 – 7:00 PM Welcome Reception – Henson Atrium, Georgia State Law Friday, June 9, 20177:30 – 8:15 AM Registration & Breakfast – Henson Atrium, Georgia State Law 8:15 – 8:30 AM Opening Remarks – Ceremonial Courtroom, Georgia State LawWendy Hensel, Interim Dean and Professor of Law, Georgia State University College of… [read post]